US Broker Ratings

BGM Group Ltd. (BGM) Stock Analysis: Navigating Volatility Amidst Healthcare Sector Challenges

Investors eyeing opportunities in the healthcare sector may find BGM Group Ltd. (BGM) to be a complex yet intriguing prospect. Based in Chengdu, China, BGM operates within the drug manufacturing..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing a 33% Upside in Biotech Innovation

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a commercial-stage biopharmaceutical company headquartered in Irvine, California, is gaining attention in the healthcare sector for its innovative approach to eye care. Despite a small..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A Healthcare Powerhouse with 17.95% Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands as a notable player in the biotechnology sector, particularly for its dedication to addressing central nervous system (CNS) disorders and rare diseases. With a..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Evaluating the Growth Potential in Rare Disease Therapeutics

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands at the forefront of biotechnology with a focus on developing therapies for rare and debilitating diseases. With a current market cap of $3.89 billion,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Major Upside Potential with a 110% Increase on the Horizon

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. Headquartered in Durham, North Carolina, this biotechnology company..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a 17.10% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a biopharmaceutical company with a focus on rare disorders, showcasing a compelling investment opportunity in the healthcare sector. With a market capitalization of $4.52..

Certara, Inc. (CERT) Stock Analysis: Unpacking a 31.88% Potential Upside in Healthcare Innovation

Certara, Inc. (NASDAQ: CERT) is an intriguing player in the healthcare sector, particularly within the health information services industry. With a market capitalization of $1.72 billion, Certara offers a unique..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 7.94% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, offers a compelling investment case for individual investors. Headquartered in..

Premier, Inc. (PINC) Stock Analysis: Navigating a Challenging Landscape with Strategic Resilience

Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.24 billion, this Charlotte, North..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: Unpacking a Promising 41% Potential Upside in Biotechnology

Investors seeking opportunities in the healthcare sector, particularly within biotechnology, should turn their attention to Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY). With a market capitalization of $2.06 billion, this commercial-stage..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 27% Potential Upside with Strong Buy Ratings

For investors seeking promising opportunities in the healthcare sector, Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) may warrant a closer look. This London-based biopharmaceutical company is making waves with its innovative therapies..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating a 52.81 Forward P/E in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Warby Parker Inc. (NYSE: WRBY) presents an intriguing case. With a market capitalization of $3.26 billion, the eyewear company has carved out..

UFP Technologies, Inc. (UFPT) Stock Analysis: A 60% Upside Potential in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is attracting considerable attention from investors, particularly in the healthcare sector, where it has carved a niche as a key player in the medical devices..

NewAmsterdam Pharma (NAMS) Stock Analysis: Potential 63% Upside in Pioneering Biotech

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering force in the biotechnology sector, is capturing investor interest with its promising pipeline and significant potential upside. Headquartered in Naarden, the Netherlands,..

Scholar Rock Holding Corporation (SRRK): Investor Outlook on a Biotech Powerhouse with 58% Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out as a compelling investment opportunity in the biotechnology sector, particularly for investors with a keen interest in companies poised for substantial growth..

CG Oncology (CGON) Stock Analysis: 75% Upside Potential in Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON) is generating a buzz in the biotechnology sector with its impressive potential upside, making it a compelling consideration for investors seeking growth in the healthcare..

Ascentage Pharma Group (AAPG): Navigating the Biotech Terrain with an Eye on Innovation

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is carving out a niche in the healthcare sector with its focus on developing therapies for cancers,..

Acadia Healthcare Company, Inc. (ACHC) Investor Outlook: Analyzing a 35% Upside Potential with Strategic Growth

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a significant player in the behavioral healthcare sector, serving the United States and Puerto Rico with a diverse range of services. With a..

Perrigo Company plc (PRGO) Investor Outlook: Evaluating a Compelling 53% Upside Potential

Perrigo Company plc (NYSE: PRGO), a Dublin-based leader in the healthcare sector, has grabbed investor attention with its promising 53.38% upside potential. Specializing in over-the-counter health and wellness solutions, the..

Concentra Group Holdings Parent (CON): Investor Outlook with a Promising 23.68% Upside Potential

Concentra Group Holdings Parent, Inc. (NYSE: CON), a prominent player in the healthcare sector, offers investors an intriguing opportunity with its strong market positioning and strategic offerings in occupational health..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds